The Effects of Probiotic Supplementation on the Incidence of Diarrhea in Cancer Patients Receiving Radiation Therapy: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials
Authors:
- Navin Kumar DevarajNDNavin Kumar Devaraj
- Subapriya SuppiahSSSubapriya Suppiah
- Sajesh K. VeettilSVSajesh K. Veettil
- Siew Mooi ChingSCSiew Mooi Ching
- Kai Wei LeeKLKai Wei Lee
- Rohit Kunnath MenonRMRohit Kunnath Menon
- Man Jun SooMSMan Jun Soo
- Inas DeurasehIDInas Deuraseh
- Fan Kee HooFHFan Kee Hoo
- Dhashani SivaratnamDSDhashani Sivaratnam
Open Access
Abstract
The protective effects of probiotic supplementation against radiation-induced diarrhea (RID) have been reported in previous systematic reviews; however so far, only non-conclusive results have been obtained. The objective of this study was to systematically update and evaluate the available evidence for probiotic supplementation. The protocol of this systematic review has been registered (CRD42018106059) with the International Prospective Register of Systematic Reviews (PROSPERO). The primary efficacy outcome was the incidence of RID. Secondary outcomes were the incidence of watery stool, soft stool, and antidiarrheal medication use. There were eight trials, and a total of 1116 participants were included in the primary analysis. Compared with placebo, probiotics were associated with a lower risk of RID [risk ratio (RR) = 0.62, 95% CI = 0.46, 0.83]. A requisite heterogeneity-adjusted trial sequential analysis indicated conclusive evidence for this beneficial effect. No statistically significant reduction in RID (RR = 0.52, 95% CI = 0.14, 1.91) was observed on subgroup analysis in patients receiving both radiation therapy and chemotherapy. However, those patients receiving only radiation therapy (RT) demonstrated significant benefit (RR = 0.61, 95% CI = 0.48, 0.78). There was a significant difference in the antidiarrheal medication use (RR = 0.54, 95% CI = 0.35, 0.84) observed with the use of probiotics. However, no significant difference was observed for the incidence of soft and watery stool. The use of probiotics is beneficial in preventing RID in patients receiving RT.Keywords
This publication has 26 references indexed in Scilit:
- World Gastroenterology Organisation Global GuidelinesJournal of Clinical Gastroenterology, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Bacteria Penetrate the Inner Mucus Layer before Inflammation in the Dextran Sulfate Colitis ModelPLOS ONE, 2010
- Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patientsRadiation Oncology, 2010
- P112 EFFECTS OF PROBIOTIC IN PREVENTION OF RADIATION-INDUCED DIARRHEAClinical Nutrition Supplements, 2009
- Effects of Probiotic Lactobacillus Casei DN-114 001 in Prevention of Radiation-Induced Diarrhea: Results From Multicenter, Randomized, Placebo-Controlled Nutritional TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysisJournal of Clinical Epidemiology, 2008
- Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment complianceEuropean Journal of Cancer, 2004
- Stool Form Scale as a Useful Guide to Intestinal Transit TimeScandinavian Journal of Gastroenterology, 1997